Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

IsraelRecruitingPHASE2

Conditions

Hematologic Malignancies · Waldenstroms Macroglobulinaemia · Non-Hodgkins Lymphoma · Chronic Lymphocytic Leukaemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Highlands Oncology Group ( Site 2728), Springdale, Arkansas, United States

    Study coordinator · 479-872-8130
  • University of California San Diego Moores Cancer Center ( Site 2717), La Jolla, California, United States

    Study coordinator · 858-534-5201
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724), Torrance, California, United States

  • Colorado Blood Cancer Institute ( Site 2726), Denver, Colorado, United States

    Study coordinator · 720-754-4800
  • The University of Louisville, James Graham Brown Cancer Center ( Site 2729), Louisville, Kentucky, United States

  • Mayo Clinic - Rochester ( Site 2706), Rochester, Minnesota, United States

  • Astera Cancer Care ( Site 2732), East Brunswick, New Jersey, United States

    Study coordinator · 732-672-6405
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 2704), Hackensack, New Jersey, United States

    Study coordinator · 551-996-3003
  • Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 2708), Fargo, North Dakota, United States

  • UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas, Texas, United States

    Study coordinator · 972-695-9450
  • Medical Oncology Associates (Summit Cancer Centers) ( Site 2710), Spokane, Washington, United States

    Study coordinator · 509-462-2273
  • Hospital Aleman ( Site 0102), Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

    Study coordinator · +541148277000
  • Centro de Educación Médica e Investigaciones Clínicas (CEMIC) ( Site 0103), Buenos Aires, Buenos Aires F.D., Argentina

    Study coordinator · +541152990247
  • Fundacion Estudios Clinicos ( Site 0112), Rosario, Santa Fe Province, Argentina

    Study coordinator · +54 0341 238 4171
  • FUNDALEU ( Site 0104), Caba, Argentina

    Study coordinator · 5411 48771046
  • Hospital Privado Universitario de Córdoba ( Site 0107), Córdoba, Argentina

    Study coordinator · +541569634187
  • Fundacion Centro Oncologico de Integración Regional-Medical Oncology ( Site 0110), Mendoza, Argentina

  • Nepean Hospital-Nepean Cancer Care Centre ( Site 0204), Sydney, New South Wales, Australia

  • Box Hill Hospital ( Site 0203), Box Hill, Victoria, Australia

    Study coordinator · +611300342255
  • Sir Charles Gairdner Hospital ( Site 0200), Nedlands, Western Australia, Australia

    Study coordinator · +61864573333
  • Hospital das Clinicas FMUSP-Pesquisa Clínica Hematologia ( Site 0303), São Paulo, São Paulo, Brazil

    Study coordinator · 551145737543
  • Instituto Nacional do Cancer Jose Alencar Gomes da Silva INCA ( Site 0300), Rio de Janeiro, Brazil

    Study coordinator · +552132076564
  • BP - A Beneficencia Portuguesa de São Paulo ( Site 0302), São Paulo, Brazil

  • Hospital Paulistano - Amil Clinical Research ( Site 0311), São Paulo, Brazil

    Study coordinator · +551130161340
  • Arthur J.E. Child Comprehensive Cancer Centre ( Site 0401), Calgary, Alberta, Canada

    Study coordinator · 4035213723
  • The Ottawa Hospital ( Site 0404), Ottawa, Ontario, Canada

    Study coordinator · 613 737-7700
  • Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0406), Toronto, Ontario, Canada

    Study coordinator · 416-946-2827
  • CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 0403), Montreal, Quebec, Canada

    Study coordinator · 5142523400
  • Jewish General Hospital ( Site 0400), Montreal, Quebec, Canada

    Study coordinator · 5143408222 x 24572
  • Anhui Provincial Hospital ( Site 2808), Hefei, Anhui, China

    Study coordinator · 13866173932
  • Peking University Third Hospital-Hematology ( Site 2827), Beijing, Beijing Municipality, China

    Study coordinator · 010-82266699
  • The Second Affiliated Hospital of Chongqing Medical University ( Site 2825), Chongqing, Chongqing Municipality, China

  • Sun Yat-sen University Cancer Center-Internal Medicine ( Site 2824), Guangzhou, Guangdong, China

    Study coordinator · (+86)13719189172
  • Liuzhou People's Hospital ( Site 2817), Liuzhou, Guangxi, China

    Study coordinator · +8607722662950
  • Guangxi Medical University Cancer Hospital ( Site 2814), Nanning, Guangxi, China

    Study coordinator · +8607715323174
  • Henan Cancer Hospital-hematology department ( Site 2802), Zhengzhou, Henan, China

    Study coordinator · 0371-65588007
  • Wuhan Union Hospital ( Site 2816), Wuhan, Hubei, China

    Study coordinator · +8618627091655
  • The Second Xiangya Hospital of Central South University ( Site 2820), Changsha, Hunan, China

    Study coordinator · +8613975806137
  • Hunan Cancer Hospital ( Site 2822), Changsha, Hunan, China

    Study coordinator · 0731-88651669
  • Jiangsu Province Hospital ( Site 2823), Nanjing, Jiangsu, China

    Study coordinator · 025-86211033
  • The Affiliated Hospital of Xuzhou Medical College ( Site 2818), Xuzhou, Jiangsu, China

  • The First Affiliated Hospital of Nanchang University ( Site 2815), Nanchang, Jiangxi, China

    Study coordinator · 13970038386
  • The First Hospital of Jilin University-Hematology ( Site 2803), Changchun, Jilin, China

    Study coordinator · 0431-88786014
  • Fudan University Shanghai Cancer Center ( Site 2801), Shanghai, Shanghai Municipality, China

    Study coordinator · +8602164175590
  • Huashan Hospital, Fudan University ( Site 2821), Shanghai, Shanghai Municipality, China

    Study coordinator · 021-52889999
  • West China Hospital Sichuan University ( Site 2810), Chengdu, Sichuan, China

    Study coordinator · +86028-85422114
  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Unio ( Site 2800), Tianjin, Tianjin Municipality, China

    Study coordinator · +8615900265415
  • The First Affiliated Hospital, Zhejiang University ( Site 2826), Hangzhou, Zhejiang, China

    Study coordinator · 057187236114
  • Fakultní nemocnice Brno Bohunice-Interni hematologicka a onkologicka klinika ( Site 0600), Brno, Brno-mesto, Czechia

    Study coordinator · +420532233642
  • Fakultni nemocnice Hradec Kralove ( Site 0601), Hradec Králové, Czechia

    Study coordinator · +420495832159
  • Aarhus University Hospital ( Site 0702), Aarhus N, Central Jutland, Denmark

  • Aalborg Universitetshospital ( Site 0703), Aalborg, North Denmark, Denmark

    Study coordinator · +45 97660000
  • Sjaellands Universitetshospital Roskilde ( Site 0701), Roskilde, Region Sjælland, Denmark

    Study coordinator · +45 46323200
  • Odense University Hospital ( Site 0705), Odense C, Region Syddanmark, Denmark

  • Centre Hospitalier Universitaire de Nice - Hôpital l'Archet ( Site 0810), Nice, Alpes-Maritimes, France

    Study coordinator · +33 4 92 03 57 85
  • Centre Hospitalier Lyon-Sud ( Site 0804), Pierre-Bénite, Auvergne-Rhône-Alpes, France

    Study coordinator · +33478864348
  • Institut Paoli-Calmettes ( Site 0803), Marseille, Bouches-du-Rhone, France

    Study coordinator · +33491223537
  • Centre Hospitalier de Versailles ( Site 0809), Le Chesnay, Yvelines, France

  • Hopital Saint Louis ( Site 0805), Paris, France

    Study coordinator · +33142499236
  • Universitaetsklinikum Ulm. ( Site 0906), Ulm, Baden-Wurttemberg, Germany

    Study coordinator · + 49 731 500 45901
  • Universitaetsklinikum Koeln ( Site 0901), Cologne, North Rhine-Westphalia, Germany

    Study coordinator · +4922147897046
  • St. Marien-Krankenhaus Siegen ( Site 0914), Siegen, North Rhine-Westphalia, Germany

  • Universitaetsklinikum Carl Gustav Carus ( Site 0902), Dresden, Saxony, Germany

    Study coordinator · 0049 351 458 5692
  • Pecsi Tudomanyegyetem Altalanos Orvostudomanyi Kar ( Site 1202), Pécs, Baranya, Hungary

    Study coordinator · +3672536000
  • Debreceni Egyetem Klinikai Kozpont ( Site 1201), Debrecen, Hajdú-Bihar, Hungary

    Study coordinator · +3652255196
  • Szabolcs Szatmár Bereg Vármegyei Oktatókórház ( Site 1206), Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary

    Study coordinator · +3642599700
  • Orszagos Onkologiai Intezet ( Site 1200), Budapest, Hungary

    Study coordinator · +3612248600
  • Beaumont Hospital ( Site 2900), Dublin, Ireland

    Study coordinator · +35318092010
  • University Hospital Limerick ( Site 2903), Limerick, Ireland

    Study coordinator · +35361588320
  • Ha Emek Medical Center ( Site 1305), Afula, Israel

    Study coordinator · 972-46494052
  • Soroka Medical Center ( Site 1307), Beersheba, Israel

    Study coordinator · +97286403827
  • Rambam Medical Center ( Site 1301), Haifa, Israel

    Study coordinator · +97247772547
  • Hadassah Ein Karem Jerusalem ( Site 1300), Jerusalem, Israel

    Study coordinator · +97226778180
  • Chaim Sheba Medical Center ( Site 1302), Ramat Gan, Israel

    Study coordinator · +97235308401
  • Kaplan Medical Center ( Site 1304), Rehovot, Israel

    Study coordinator · +97289441726
  • Sourasky Medical Center ( Site 1303), Tel Aviv, Israel

    Study coordinator · +97236973782
  • Istituto Tumori Giovanni Paolo II ( Site 1409), Bari, Italy

  • A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 1400), Bologna, Italy

    Study coordinator · +390516363680
  • ASST Spedali Civili di Brescia ( Site 1408), Brescia, Italy

    Study coordinator · +39 0303996416
  • IRCCS Ospedale San Raffaele ( Site 1402), Milan, Italy

    Study coordinator · 00390226434797
  • Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1403), Naples, Italy

    Study coordinator · +39 0815903 382
  • Fondazione IRCCS Policlinico San Matteo ( Site 1407), Pavia, Italy

    Study coordinator · +39 0382503084
  • IRCCS - Arcispedale Santa Maria Nuova ( Site 1405), Reggio Emilia, Italy

    Study coordinator · +39 0522295654
  • Policlinico Umberto I ( Site 1404), Roma, Italy

  • Pratia MCM Krakow ( Site 1601), Krakow, Lesser Poland Voivodeship, Poland

    Study coordinator · 48 12 2954135
  • Uniwersytecki Szpital Kliniczny-Klinika Hematologii, Nowotworow Krwi i Transplantacji Szpiku ( Site 1606), Wroclaw, Lower Silesian Voivodeship, Poland

    Study coordinator · +48717842576
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Kilinka Onkologii I Hematologii ( Site 1608), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · +48225462223
  • Szpital Wojewódzki w Opolu-Hematology Department ( Site 1607), Opole, Opole Voivodeship, Poland

  • Szpitale Pomorskie Sp. z o.o. ( Site 1600), Gdynia, Pomeranian Voivodeship, Poland

  • Spitalul Clinic Colțea ( Site 1805), Bucharest, Bucharest, Romania

    Study coordinator · 0040213874100
  • Ovidius Clinical Hospital ( Site 1804), Ovidiu, Constanța County, Romania

  • Centrul de Diagnostic si Tratament Oncologic Brasov ( Site 1802), Brasov, Romania

    Study coordinator · 0729075567
  • Institutul Regional de Oncologie Iasi ( Site 1801), Iași, Romania

    Study coordinator · 40374278811
  • Severance Hospital Yonsei University Health System ( Site 2201), Seoul, South Korea

    Study coordinator · +82222281972
  • Samsung Medical Center ( Site 2200), Seoul, South Korea

    Study coordinator · +82234106548
  • Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 2000), L'Hospitalet de Llobregat, Barcelona, Spain

    Study coordinator · +34932607750
  • Hospital Universitario de Salamanca ( Site 2002), Salamanca, Castille and León, Spain

    Study coordinator · 34923 29 11 00x55974
  • CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 2005), A Coruña, La Coruna, Spain

    Study coordinator · 34981178000
  • Hospital General Universitario de Alicante ( Site 2007), Alicante, Spain

    Study coordinator · 965 93 30 00
  • Hospital Universitari Vall d'Hebron ( Site 2001), Barcelona, Spain

    Study coordinator · +34934893806
  • Hospital Universitario 12 de Octubre ( Site 2003), Madrid, Spain

    Study coordinator · +34917792809
  • Hospital Puerta de Hierro ( Site 2009), Madrid, Spain

    Study coordinator · +34911916000
  • Inselspital Bern ( Site 2303), Bern, Canton of Bern, Switzerland

    Study coordinator · +41316329023
  • Istituto Oncologica della Svizzera Italiana (IOSI) ( Site 2302), Bellinzona, Canton Ticino, Switzerland

    Study coordinator · +41918118540
  • Mega Medipol-Hematology ( Site 2406), Stanbul, Istanbul, Turkey (Türkiye)

  • Ankara Universitesi Tip Fakultesi Cebeci Hastanesi ( Site 2400), Ankara, Turkey (Türkiye)

    Study coordinator · +903125957099
  • VKV Amerikan Hastanesi ( Site 2403), Istanbul, Turkey (Türkiye)

  • Sisli Florence Nightingale Hastanesi ( Site 2407), Istanbul, Turkey (Türkiye)

    Study coordinator · +90 542 502 50 75
  • Dokuz Eylül Üniversitesi-Hematology ( Site 2402), Izmir, Turkey (Türkiye)

  • MNPE ClinCenter of Oncology,Hematology,Transplantology and Palliative Care of CherkasyRegCouncil ( Site 2509), Cherkassy, Cherkasy Oblast, Ukraine

  • Communal non-profit enterprise "Regional clinical hospital o-Hematology Department ( Site 2510), Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine

  • Instit. of Blood Transfusion Medicine of the National Academy ( Site 2506), Lviv, Lviv Oblast, Ukraine

    Study coordinator · +380322352276
  • National Cancer Institute ( Site 2507), Kyiv, Ukraine

    Study coordinator · +380672091427
  • Bristol Haematology and Oncology Centre ( Site 2610), Bristol, Bristol, City of, United Kingdom

    Study coordinator · 01173426733
  • Nottingham University Hospitals NHS Trust. City Hospital Campus ( Site 2601), Nottingham, England, United Kingdom

    Study coordinator · +441159691169
  • GenesisCare - Windsor ( Site 2608), Windsor, England, United Kingdom

    Study coordinator · +447989474250
  • Sarah Cannon Research Institute UK ( Site 2612), London, London, City of, United Kingdom

    Study coordinator · 02032195234
  • GenesisCare - Oxford ( Site 2607), Oxford, Oxfordshire, United Kingdom

    Study coordinator · +447989474250
  • GenesisCare - Cambridge ( Site 2611), Newmarket, Suffolk, United Kingdom

    Study coordinator · 01223 655145
  • The Royal Marsden NHS Foundation Trust. ( Site 2606), Sutton, Surrey, United Kingdom

    Study coordinator · 020 8642 6011
  • The Christie NHS Foundation Trust ( Site 2602), Manchester, United Kingdom

    Study coordinator · 01619561217
Study leads
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC